IRadimed Corporation
IRadimed Corporation (NASDAQ: IRMD) is trading at $85.76, about ₹8,226 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.66% today. Indian residents can buy IRadimed from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$84.77
Today's high
$86.24
52 week low
$67.84
52 week high
$107.90
IRMD opened at $85.19, closed previously at $85.20, and has traded between $67.84 and $107.90 over the past 52 weeks.
About
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Key statistics
Avg. volume
134.21K
Market cap
$1.10B
P/E Ratio
47.12
Price-to-sales ratio
12.70
Enterprise value
$1.04B
Free cash flow yield
2.27%
Debt-to-equity ratio
0.00
Return on equity
23.45%
ROIC
20.18%
Beta
0.90
Dividend yield
1.48%
Last dividend
$1.27
Financial overview
Revenue
$83.81M
Earnings per share
$1.77
Free cash flow
$17.18M
Net profit margin
26.70%
Gross margin
75.86%
EBITDA
$30.74M
Revenue growth
14.43%
Similar securities
This is not an investment recommendation
How to buy IRadimed from India
Indian residents can buy IRadimed shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for IRadimed and place an order
Find IRadimed by name or by its ticker, IRMD, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. IRadimed trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your IRadimed position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in IRadimed from India
Trading and taxes when buying IRadimed from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. IRadimed’s current yield is 1.48%.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy IRadimed stock?
Yes. IRadimed (IRMD) has been listed on NASDAQ since 2014, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one IRadimed share cost in rupees?
One IRadimed share is $85.76 — about ₹8,226 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the IRadimed price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying IRadimed from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of IRadimed?
Yes. One IRadimed share is $85.76, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in IRadimed.
How are gains on IRadimed shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the IRadimed price. Paasa issues a capital-gains statement for your return.
Does IRadimed pay a dividend, and how is it taxed in India?
Yes. IRadimed pays a dividend and the current yield is 1.48%; the last declared dividend was $1.27 per share, about ₹121.82. Dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade IRadimed from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on IRadimed shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare IRadimed shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your IRadimed holding, its cost and its closing value.
How do I sell IRadimed and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.